Skip to content

A comparative study of the intestinal flora of untreated postmenopausal breast cancer patients and healthy postmenopausal individuals and a preliminary study of soymilk beverage acceptability in a group of breast cancer patients

A comparative study of the intestinal flora of untreated postmenopausal breast cancer patients and healthy postmenopausal individuals and a preliminary study of soymilk beverage acceptability in a group of breast cancer patients - A comparative study of the intestinal flora of untreated postmenopausal breast cancer patients and healthy postmenopausal individuals and a preliminary study of soymilk beverage acceptability in a group of breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043339
Enrollment
60
Registered
2021-03-10
Start date
2021-03-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

with soymilk without soymilk

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Postmenopausal women (2) The age at the time of obtaining document consent is 20 years or older. (3) ECOG Performance Status (PS) is 0 or 1. (4) Those who have a constant daily diet and a constant daily rhythm (5) Those whose inspection values are within the normal range (6) Histological diagnosis of breast cancer has been obtained (7) Primary untreated primary breast cancer without distant metastasis (8) Scheduled surgery for breast cancer (assuming no preoperative treatment) (9) Do not have double cancer

Exclusion criteria

Exclusion criteria: (1) Those who cannot drink soy milk (2) Those who drink soy milk on a daily basis (3) Those who have a history of food allergies that are problematic when participating in the study, including allergies to soybeans, milk, and soymilk. (4) Those who regularly use foods that may affect intestinal regulation, foods for specified health use, foods with functional claims, supplements, and health foods at least 3 times a week (5) Those who are taking antibiotics within 2 weeks before registration (6) Those who took intestinal regulators and laxatives within 1 month before registration (7) Alcoholic drinkers (8) Those who have extremely irregular eating habits, those who have irregular lifestyles such as shift workers and late-night workers (9) Those who have been treated for gastrointestinal diseases within 6 months before registration (10) Those who have a history of surgery within 6 months before registration (11) Those who have an active infectious disease that requires treatment (12) Those who have diarrhea requiring treatment (13) People with constipation who often have no bowel movements for more than a week (14) Those who are undergoing treatment for constipation or constipation that requires treatment (15) Those with inflammatory bowel disease (16) Those with a BMI of 25 or above (17) Those who have an artificial anus (18) Those who have had intestinal obstruction (ileus) in the past (19) Those who have had severe abdominal pain or black stools within the past week (20) Those who are on dialysis (21) Those who have undergone breast augmentation surgery (22) Those who have been diagnosed with hay fever and who are taking over-the-counter medicine due to subjective symptoms of hay fever (23) Those with severe medical illness, signs of psychiatric or neurological illness that do not comply with the provisions of this study (24) Others who are deemed inappropriate as the subject of this study by the principal investigator, etc.

Design outcomes

Primary

MeasureTime frame
1) Acceptability of soymilk in Japanese breast cancer patients 2) Composition of intestinal flora between patients who drink the soymilk and who do not drink

Countries

Japan

Contacts

Public ContactMasahiro Takada

Kyoto University Hospital Breast Surgery

masahiro@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026